Bardoxolone methyl (BM) prevents high-fat (HF) diet-induced cardiac hypertrophy.
BM prevents HF diet-induced renal corpuscle hypertrophy.
BM prevents HF diet-induced fat accumulation and inflammation in the heart.
BM prevents HF diet-induced fat accumulation and inflammation in the kidneys.
BM prevents HF diet-induced elevations in renal endothelin signalling.